ABOS
Price
$1.09
Change
+$0.07 (+6.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
59.49M
26 days until earnings call
PYXS
Price
$1.08
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
62.82M
15 days until earnings call
Ad is loading...

ABOS vs PYXS

Header iconABOS vs PYXS Comparison
Open Charts ABOS vs PYXSBanner chart's image
Acumen Pharmaceuticals
Price$1.09
Change+$0.07 (+6.86%)
Volume$8.04K
Capitalization59.49M
Pyxis Oncology
Price$1.08
Change-$0.00 (-0.00%)
Volume$2.2K
Capitalization62.82M
ABOS vs PYXS Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. PYXS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and PYXS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ABOS: $1.02 vs. PYXS: $1.08)
Brand notoriety: ABOS and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 149% vs. PYXS: 117%
Market capitalization -- ABOS: $59.49M vs. PYXS: $62.82M
ABOS [@Biotechnology] is valued at $59.49M. PYXS’s [@Biotechnology] market capitalization is $62.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 2 bearish.
  • PYXS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than PYXS.

Price Growth

ABOS (@Biotechnology) experienced а +4.08% price change this week, while PYXS (@Biotechnology) price change was +15.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

PYXS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($62.8M) has a higher market cap than ABOS($59.5M). PYXS YTD gains are higher at: -30.769 vs. ABOS (-40.698). PYXS has higher annual earnings (EBITDA): -64.04M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. PYXS (145M). PYXS has less debt than ABOS: PYXS (20.5M) vs ABOS (28.5M). PYXS has higher revenues than ABOS: PYXS (16.1M) vs ABOS (0).
ABOSPYXSABOS / PYXS
Capitalization59.5M62.8M95%
EBITDA-77.89M-64.04M122%
Gain YTD-40.698-30.769132%
P/E RatioN/AN/A-
Revenue016.1M-
Total Cash200M145M138%
Total Debt28.5M20.5M139%
TECHNICAL ANALYSIS
Technical Analysis
ABOSPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIST1.160.10
+9.43%
Milestone Pharmaceuticals
GSBD10.670.15
+1.43%
Goldman Sachs BDC
BLK892.545.32
+0.60%
Blackrock
LSTR138.150.77
+0.56%
Landstar System
ANIK14.09-0.11
-0.77%
Anika Therapeutics

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ATOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+3.86%
ATOS - ABOS
54%
Loosely correlated
+11.25%
FHTX - ABOS
50%
Loosely correlated
+10.38%
BEAM - ABOS
48%
Loosely correlated
+3.87%
GBIO - ABOS
48%
Loosely correlated
+9.99%
CRBU - ABOS
47%
Loosely correlated
+0.79%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been closely correlated with KURA. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+5.88%
KURA - PYXS
67%
Closely correlated
+0.95%
BLRX - PYXS
45%
Loosely correlated
+2.41%
ABOS - PYXS
42%
Loosely correlated
+3.86%
BEAM - PYXS
41%
Loosely correlated
+3.87%
RXRX - PYXS
39%
Loosely correlated
-0.89%
More